September 2023 Price Concessions 2nd Update


Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (27/09/2023) announced the following list of price concessions for September 2023:

Drug Pack size Price concession
Atomoxetine 10mg capsules 28 £44.45
Atomoxetine 18mg capsules 28 £42.95
Atomoxetine 25mg capsules 28 £43.21
Atomoxetine 40mg capsules 28 £48.84
Atomoxetine 60mg capsules 28 £48.48
Beclometasone 50micrograms/dose nasal spray 200 £2.63
Calamine lotion 200 £1.92
Chlorphenamine 2mg/5ml oral solution sugar free 150 £7.63
Clarithromycin 250mg/5ml oral suspension 70 £5.18
Co-beneldopa 12.5mg/50mg capsules 100 £4.82
Codeine 30mg tablets 28 £1.08
Codeine 30mg tablets 100 £3.86
Hydrocortisone 1% cream 50 £3.30
Lactulose 3.1-3.7g/5ml oral solution 500 £2.97
Lansoprazole 15mg orodispersible tablets 28 £2.90
Mebeverine 50mg/5ml oral suspension sugar free 300 £214.96
Ondansetron 4mg tablets 10 £7.10
Rosuvastatin 40mg tablets 28 £1.70
Simvastatin 80mg tablets 28 £1.51
Sulpiride 200mg/5ml oral solution sugar free 150 £101.58
Travoprost 40micrograms/ml / timolol 5mg/ml eye drops 2.5 £5.17
There are no prices that rolled over from the previous month.

For the full list of price concessions granted so far for September 2023, please visit our webpage:

No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.

We encourage pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC. We are still working with the DHSC to agree concessionary prices for other drugs reported to be unavailable at the stated September Drug Tariff price. Please note that we cannot provide details of any generic products awaiting price concession approval from DHSC.

Please  subscribe to our mailing list to receive email updates of any price concessions.

Further information on price  concessions and FAQs about the process  involved  can be found on our website ( To hear more on how the current price  concessions system operates, pharmacy teams can now access a recording of our recent Medicines Supply and Concessions Briefing webinar  here.

Improvements to the price concession system

Following significant concerns raised by pharmacies about the unsustainable level of prices imposed by  DHSC  in second half of 2022, it was agreed that an  urgent review of the price concession setting system would take place.

Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system.

One of the solutions agreed between us and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.

Furthermore, from May 2023, DHSC has implemented a process to roll over prices to the following month for any concessions requested after the 23rd of the month provided these prices were agreed with us. We are also continuing to work with DHSC on how a ‘retrospective increased payment’ may apply, where appropriate. Further information regarding this concession ‘top-up’ mechanism will be issued once details are finalised.